GlassScriptPhysician profile
Rodney L Myers
NPI 1740211044
$6,159.83
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,844 · 2020: $1,126 · 2021: $2,190.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $580.47 | 2019-2021 | |
| Amgen INC. | $566.30 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $465.19 | 2019-2021 | |
| Emd Serono, INC. | $448.46 | 2019-2021 | |
| Ucb, INC. | $438.10 | 2019-2021 | |
| Csl Behring | $383.11 | 2019-2021 | |
| Allergan, INC. | $371.73 | 2020-2021 | |
| Lundbeck LLC | $366.43 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $280.56 | 2019-2021 | |
| Abbvie INC. | $274.11 | 2021 | |
| Livanova USA, INC. | $247.96 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $238.42 | 2019-2020 | |
| Sk Life Science, INC. | $208.39 | 2020-2021 | |
| Lilly USA, LLC | $178.34 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $142.40 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $131.58 | 2020-2021 | |
| Grifols USA, LLC | $117.99 | 2019 | |
| Genentech USA, INC. | $78.33 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $72.90 | 2020-2021 | |
| Mdd US Operations, LLC | $70.45 | 2019 | |
| Upsher-Smith Laboratories LLC | $69.14 | 2020-2021 | |
| Optinose US, INC. | $57.47 | 2019 | |
| Kyowa Kirin, INC. | $53.50 | 2020-2021 | |
| Acadia Pharmaceuticals INC | $52.97 | 2020 | |
| Avanir Pharmaceuticals, INC. | $52.33 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $48.07 | 2019 | |
| Zyla Life Sciences, INC. | $41.05 | 2019 | |
| Adamas Pharmaceuticals, INC. | $22.37 | 2021 | |
| United Therapeutics Corporation | $20.08 | 2019 | |
| Shire North American Group INC | $16.97 | 2019 | |
| Chiesi USA, INC. | $16.51 | 2019 | |
| Mylan Specialty L.P. | $16.48 | 2019 | |
| Portola Pharmaceuticals, LLC | $16.41 | 2019 | |
| Acorda Therapeutics, INC | $15.26 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.